An interventional study of non White coat in Patient Satisfaction, sponsored by The University of Texas Medical Branch, Galveston. Completed at 1 site in United States. Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-02-05.
Sponsored by The University of Texas Medical Branch, Galveston · Not applicable, Interventional, and Other
Among 198 studies in Patient Satisfaction with a site in United States — 30 open to participants now, 35 under way, none of them phase 3. Patient Satisfaction · United States.
Among the 198 studies in Patient Satisfaction with a site in United States, this one is the 42nd largest by enrollment of the 162 interventional ones that give a count, is one of 5 that started in 2017, is one of 137 with no phase, and was the 78th registered.
877 studies on the registry are indexed under Patient Satisfaction; 202 are open to participants now.
Browse Patient Satisfaction studies →30 of the 198 studies in Patient Satisfaction with a site in United States are open now. Recruiting first, the newest first:
Montefiore Medical Center · Sites in United States
University of Chicago · Sites in United States
University of California, Los Angeles · Sites in United States
Children's National Research Institute · Sites in United States
VA Office of Research and Development · Sites in United States
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 99 Patient Satisfaction studies recruiting now, 61 (62%) set no upper age limit and 30 (30%) stop at 75 or younger; 14 take children under 18; 26 take healthy volunteers.
This study: 18 Years to 50 Years · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
198 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 5 · Phase 3 1 · Phase 4 18
First in 1999; this study’s year is marked. 5 started in 2017.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 178 is above the median of 96 across 624 interventional studies indexed under Patient Satisfaction.
Median enrollment 100 across the 162 interventional studies, 160 across the 36 observational. Of the 146 that completed or were terminated, 42 (29%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 198 have an industry lead sponsor. The 10 most frequent:
The University of Texas Medical Branch, Galveston is the lead sponsor of 257 studies on the registry; 38 are open to participants now.
Of its 32 completed or terminated interventional studies of FDA-regulated products, 26 (81%) have results posted.
The University of Texas Medical Branch, Galveston has 1 study filed under Patient Satisfaction — fewer than ten, so there is no comparison to draw.
17 of the studies in Patient Satisfaction with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06799052Boston Medical CenterCervical Preparation for Same-Day Dilation & Evacuation | 2026-12 |
| NCT06790043Albany Medical CollegeImpact of Patient Selected Visual Art in the Hospital Room During Antepartum Admission on Hospital Satisfaction Scores and Patient Experience | 2026-12 |
| NCT06975033University of California, San FranciscoEducational Discharge Video Impact on Post-Operative Healthcare Utilization After HoLEP | 2026-12-01 |
| NCT07715591University of California, Los AngelesRandomized Controlled Trial of the STEIN Protocol: A Neuroplastic Pain Education and Guided Breathing Intervention During Awake Cataract Surgery | 2026-12-31 |
| NCT07821476Gebauer CompanyIs Pain Ease (New Formula) Safe and Effective in Reducing Pain Associated With Peripheral Intravenous Cannulation (PIV)? | 2027-01 |
Among the 198 studies in Patient Satisfaction with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Wearing white coat during hospital rounds has been associated with increased risk of colonization and transmission of resistant pathogens. On the other hand, studies have shown that physicians' attire affects patients' confidence in their physician and the patient-physician relationship. The results of these studies were highly dependent on the practice setting, with no data in postpartum patients.
The objective is to test the hypothesis that not wearing a white coat during physician postpartum rounds impact patient-physician communication scores.
Patient satisfaction is an important measure of quality of care. One of the most important variables in patients satisfaction scores is the physician communication skills. There have been several studies evaluating different strategies to improve the patient perceptions of patient - physician communication including delayed physician rounds, improvement of handoff strategies, and family centered rounds. Additionally, research has shown that patients develop a first impression of their physician based on the physician's verbal and nonverbal communication, including the clothing and cleanliness. Patient - physician communication scores not only have an impact on patient care, but are also now linked to Medicare reimbursements.
White coats have been widely used in the medical profession, however some physicians believe that this can be a nonverbal barrier to patient's interaction. Prior studies on the impact of physician attire have reported conflicting results. In a survey published by Cha et al, obstetric and gynecologic patients seen in the outpatient clinic preferred that the resident use white coats. Another study showed that patients favor the use of white coat in the Internal Medicine outpatient clinic which may favorably influence trust and confidence in the medical encounter.
No randomized controlled trial has been published on the impact of the use of white coat on patient - physician communication scores in the postpartum patients. This trial's primary outcome is to evaluate the impact of physician attire (specifically wearing white coat) during postpartum rounds on "patient - physician communication" scores.
This study is a randomized controlled trial performed in postpartum patients to evaluate the impact of not wearing white coat during rounds on "patient - physician communication" scores.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The postpartum physician rounding in this group will be performed wearing white coat.
Other: non White coat
The postpartum physician rounding in this group will be performed not wearing white coat.
Other: non White coat
Postpartum patients are randomized to either arm of the study (white coat or standard scrub suit only) by location. All the obstetric physicians associated with patient's postpartum care should use or not use white coat in every single encounter with patient.
Patient - physician communication score
Obtained from the three Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) questions.
Time frame: 24 to 120 hours
Hospital rating scores
Obtained from one question of the HCAHPS survey
Time frame: 24 to 120 hours
Recommending the hospital to friends and family
Obtained from one question of the HCAHPS survey
Time frame: 24 to 120 hours
Physician attire rating score
Rated from 1 to 4
Time frame: 24 to 120 hours
White coat use
Patient answer if she remember or not if their physician were using white coat.
Time frame: 24 to 120 hours
Plan to share: No
No publications or documents are linked to this record.
Ran from May 2017 to primary completion in Jun 2017, 1 month.
Of 368 non-industry interventional studies with no phase under Patient Satisfaction, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 1 month is below that.
Counting every sponsor, half of 370 studies reached it within 12 months; a quarter within 6 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The University of Texas Medical Branch, Galveston →